Orin is a very nice, pleasant person who speaks with the type of skill you'd expect out of a person who runs a 9 figure hedge fund. By that I mean he makes damn sure to let you know he cannot give any information that isn't stated in the filings, but also that Novint is something that they're active with and that they have hopes for in the future.
Honestly, the fact that they've kept it on-point with SEC filings is proof enough that that something is in the works. The lack of communication/promotion is likely due to the fact that unlike most money-grubbing OTC CEO's, they don't really have a need for pushing price higher until the time is right.